125 related articles for article (PubMed ID: 24161073)
1. The molecular landscape of diffuse glioma and prospects for biomarker development.
Huse JT; Aldape KD
Expert Opin Med Diagn; 2013 Nov; 7(6):573-87. PubMed ID: 24161073
[TBL] [Abstract][Full Text] [Related]
2. Genetics and pharmacogenomics of diffuse gliomas.
van Thuijl HF; Ylstra B; Würdinger T; van Nieuwenhuizen D; Heimans JJ; Wesseling P; Reijneveld JC
Pharmacol Ther; 2013 Jan; 137(1):78-88. PubMed ID: 22985521
[TBL] [Abstract][Full Text] [Related]
3. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches.
Riemenschneider MJ; Reifenberger G
Curr Opin Neurol; 2009 Dec; 22(6):619-24. PubMed ID: 19741528
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
6. Gliomas: advances in molecular analysis and characterization.
Boudreau CR; Yang I; Liau LM
Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087
[TBL] [Abstract][Full Text] [Related]
7. An introduction to molecular analysis and characterization of gliomas.
Ausman JI
Surg Neurol; 2005 Oct; 64(4):285. PubMed ID: 16181992
[No Abstract] [Full Text] [Related]
8. Genetic markers in adult high-grade gliomas.
Pekmezci M; Perry A
Semin Radiat Oncol; 2014 Oct; 24(4):235-9. PubMed ID: 25219807
[TBL] [Abstract][Full Text] [Related]
9. The use of global profiling in biomarker development for gliomas.
Sulman EP; Aldape K
Brain Pathol; 2011 Jan; 21(1):88-95. PubMed ID: 21129062
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of molecular markers in the diagnosis and management of diffuse glioma.
Huse JT; Aldape KD
Clin Cancer Res; 2014 Nov; 20(22):5601-11. PubMed ID: 25398843
[TBL] [Abstract][Full Text] [Related]
11. Gliomas Genomics and Epigenomics: Arriving at the Start and Knowing It for the First Time.
Filbin MG; Suvà ML
Annu Rev Pathol; 2016 May; 11():497-521. PubMed ID: 26980161
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas.
Sun Y; Wang Z; Zhou D
Med Hypotheses; 2013 Aug; 81(2):319-21. PubMed ID: 23688743
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
14. Molecular subclassification of diffuse gliomas: seeing order in the chaos.
Huse JT; Phillips HS; Brennan CW
Glia; 2011 Aug; 59(8):1190-9. PubMed ID: 21446051
[TBL] [Abstract][Full Text] [Related]
15. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
16. A 4-gene signature associated with clinical outcome in high-grade gliomas.
de Tayrac M; Aubry M; Saïkali S; Etcheverry A; Surbled C; Guénot F; Galibert MD; Hamlat A; Lesimple T; Quillien V; Menei P; Mosser J
Clin Cancer Res; 2011 Jan; 17(2):317-27. PubMed ID: 21224364
[TBL] [Abstract][Full Text] [Related]
17. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
Houshmandi SS; Surace EI; Zhang HB; Fuller GN; Gutmann DH
Neurology; 2006 Nov; 67(10):1863-6. PubMed ID: 17130425
[TBL] [Abstract][Full Text] [Related]
19. [Gene expression profiling of malignant gliomas by cDNA microarrays].
Takahashi H; Kouno J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():515-9. PubMed ID: 16201574
[No Abstract] [Full Text] [Related]
20. [Malignant glioma].
Okamura K
Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
